|
1
|
Luh SP and Chiang CH: Acute lung
injury/acute respiratory distress syndrome (ALI/ARDS): The
mechanism, present strategies and future perspectives of therapies.
J Zhejiang Univ Sci B. 8:60–69. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Matthay MA, Ware LB and Zimmerman GA: The
acute respiratory distress syndrome. J Clin Invest. 122:2731–2740.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tomashefski JF Jr: Pulmonary pathology of
acute respiratory distress syndrome. Clin Chest Med. 21:435–466.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ware LB and Matthay MA: The acute
respiratory distress syndrome. N Engl J Med. 342:1334–1349. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Orme JJ, Romney JS, Hopkins RO, Pope D,
Chan KJ, Thomsen G, Crapo RO and Weaver LK: Pulmonary function and
health-related quality of life in survivors of acute respiratory
distress syndrome. Am J Respir Crit Care Med. 167:690–694. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chida M, Ono S, Hoshikawa Y and Kondo T:
Subclinical idiopathic pulmonary fibrosis is also a risk factor of
postoperative acute respiratory distress syndrome following
thoracic surgery. Eur J Cardiothorac Surg. 34:878–881. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fukuda Y, Ishizaki M, Masuda Y, Kimura G,
Kawanami O and Masugi Y: The role of intraalveolar fibrosis in the
process of pulmonary structural remodeling in patients with diffuse
alveolar damage. Am J Pathol. 126:171–182. 1987.PubMed/NCBI
|
|
8
|
Lin P: Targeting interleukin-6 for
noninfectious uveitis. Clin Ophthalmol. 9:1697–1702. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rose-John S: The soluble interleukin-6
receptor and related proteins. Best Pract Res Clin Endocrinol
Metab. 29:787–797. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
De Lauretis A, Sestini P, Pantelidis P,
Hoyles R, Hansell DM, Goh NS, Zappala CJ, Visca D, Maher TM, Denton
CP, et al: Serum interleukin 6 is predictive of early functional
decline and mortality in interstitial lung disease associated with
systemic sclerosis. J Rheumatol. 40:435–446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
O'Donoghue RJ, Knight DA, Richards CD,
Prêle CM, Lau HL, Jarnicki AG, Jones J, Bozinovski S, Vlahos R,
Thiem S, et al: Genetic partitioning of interleukin-6 signalling in
mice dissociates Stat3 from Smad3-mediated lung fibrosis. EMBO Mol
Med. 4:939–951. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoshizaki A, Yanaba K, Ogawa A, Asano Y,
Kadono T and Sato S: Immunization with DNA topoisomerase I and
Freund's complete adjuvant induces skin and lung fibrosis and
autoimmunity via interleukin-6 signaling. Arthritis Rheum.
63:3575–3585. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Snedden WA and Fromm H: Characterization
of the plant homologue of prohibitin, a gene associated with
antiproliferative activity in mammalian cells. Plant Mol Biol.
33:753–756. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Merkwirth C and Langer T: Prohibitin
function within mitochondria: Essential roles for cell
proliferation and cristae morphogenesis. Biochim Biophys Acta.
1793:27–32. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Koushyar S, Jiang WG and Dart DA:
Unveiling the potential of prohibitin in cancer. Cancer Lett.
369:316–322. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peng YT, Chen P, Ouyang RY and Song L:
Multifaceted role of prohibitin in cell survival and apoptosis.
Apoptosis. 20:1135–1149. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sharma A and Qadri A: Vi polysaccharide of
Salmonella typhi targets the prohibitin family of molecules
in intestinal epithelial cells and suppresses early inflammatory
responses. Proc Natl Acad Sci USA. 101:17492–17497. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Theiss AL, Idell RD, Srinivasan S,
Klapproth JM, Jones DP, Merlin D and Sitaraman SV: Prohibitin
protects against oxidative stress in intestinal epithelial cells.
FASEB J. 21:197–206. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gamble SC, Chotai D, Odontiadis M, Dart
DA, Brooke GN, Powell SM, Reebye V, Varela-Carver A, Kawano Y,
Waxman J and Bevan CL: Prohibitin, a protein downregulated by
androgens, represses androgen receptor activity. Oncogene.
26:1757–1768. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Theiss AL and Sitaraman SV: The role and
therapeutic potential of prohibitin in disease. Biochim Biophys
Acta. 1813:1137–1143. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Theiss AL, Vijay-Kumar M, Obertone TS,
Jones DP, Hansen JM, Gewirtz AT, Merlin D and Sitaraman SV:
Prohibitin is a novel regulator of antioxidant response that
attenuates colonic inflammation in mice. Gastroenterology.
137(199–208): 208.e1–6. 2009.
|
|
22
|
Soulitzis N, Neofytou E, Psarrou M,
Anagnostis A, Tavernarakis N, Siafakas N and Tzortzaki EG:
Downregulation of lung mitochondrial prohibitin in COPD. Respir
Med. 106:954–961. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Agrawal T, Gupta GK and Agrawal DK:
Vitamin D deficiency decreases the expression of VDR and prohibitin
in the lungs of mice with allergic airway inflammation. Exp Mol
Pathol. 93:74–81. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ko KS, Tomasi ML, Iglesias-Ara A, French
BA, French SW, Ramani K, Lozano JJ, Oh P, He L, Stiles BL, et al:
Liver-specific deletion of prohibitin 1 results in spontaneous
liver injury, fibrosis and hepatocellular carcinoma in mice.
Hepatology. 52:2096–2108. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou TB, Qin YH, Lei FY, Huang WF and
Drummen GP: Prohibitin attenuates oxidative stress and
extracellular matrix accumulation in renal interstitial fibrosis
disease. PLoS One. 8:e771872013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sanchez-Quiles V, Segura V, Bigaud E, He
B, O'Malley BW, Santamaría E, Prieto J and Corrales FJ:
Prohibitin-1 deficiency promotes inflammation and increases
sensitivity to liver injury. J Proteomics. 75:5783–5792. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu X, Tian Y, Qu S, Cao Y, Li S, Zhang W,
Zhang Z, Zhang N and Fu Y: Protective effect of TM6 on LPS-induced
acute lung injury in mice. Sci Rep. 7:5722017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao J, He D, Su Y, Berdyshev E, Chun J,
Natarajan V and Zhao Y: Lysophosphatidic acid receptor 1 modulates
lipopolysaccharide-induced inflammation in alveolar epithelial
cells and murine lungs. Am J Physiol Lung Cell Mol Physiol.
301:L547–L556. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rocco PR, Dos SC and Pelosi P: Lung
parenchyma remodeling in acute respiratory distress syndrome.
Minerva Anestesiol. 75:730–740. 2009.PubMed/NCBI
|
|
31
|
Burnham EL, Janssen WJ, Riches DW, Moss M
and Downey GP: The fibroproliferative response in acute respiratory
distress syndrome: Mechanisms and clinical significance. Eur Respir
J. 43:276–285. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cottin V: Interstitial lung disease. Eur
Respir Rev. 22:26–32. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chapman HA: Epithelial-mesenchymal
interactions in pulmonary fibrosis. Annu Rev Physiol. 73:413–435.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dong WW, Zhang YQ, Zhu XY, Mao YF, Sun XJ,
Liu YJ and Jiang L: Protective effects of hydrogen-rich saline
against lipopolysaccharide-induced alveolar
epithelial-to-mesenchymal transition and pulmonary fibrosis. Med
Sci Monit. 23:2357–2364. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
He D, Su Y, Usatyuk PV, Spannhake EW,
Kogut P, Solway J, Natarajan V and Zhao Y: Lysophosphatidic acid
enhances pulmonary epithelial barrier integrity and protects
endotoxin-induced epithelial barrier disruption and lung injury. J
Biol Chem. 284:24123–24132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao D, Ding R, Mao Y, Wang L, Zhang Z and
Ma X: Heparin rescues sepsis-associated acute lung injury and
lethality through the suppression of inflammatory responses.
Inflammation. 35:1825–1832. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu T, Wang DX, Zhang W, Liao XQ, Guan X,
Bo H, Sun JY, Huang NW, He J, Zhang YK, et al: Andrographolide
protects against LPS-induced acute lung injury by inactivation of
NF-kappaB. PLoS One. 8:e564072013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhou TB, Qin YH, Li ZY, Xu HL, Zhao YJ and
Lei FY: All-trans retinoic acid treatment is associated with
prohibitin expression in renal interstitial fibrosis rats. Int J
Mol Sci. 13:2769–2782. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Theiss AL, Obertone TS, Merlin D and
Sitaraman SV: Interleukin-6 transcriptionally regulates prohibitin
expression in intestinal epithelial cells. J Biol Chem.
282:12804–12812. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yuan C, Chen WX, Zhu JS, Chen NW, Lu YM,
Ou YX and Chen HQ: IL-10 treatment is associated with prohibitin
expression in the Crohn's disease intestinal fibrosis mouse model.
Mediators Inflamm. 2013:6171452013. View Article : Google Scholar : PubMed/NCBI
|
